KURE ETF
KraneShares MSCI All China Health Care Index ETF
6160:HK is KURE's largest holding at 8.83% of the fund as of Oct 1, 2026. KURE is KraneShares MSCI All China Health Care Index ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | O | Beigene Ag | 8.83% | 8.8% | 351,518 | $10.10M | - | - |
| 2 | — | Innovent Biologics IncHealth Care · Biotechnology | 8.56% | 17.4% | 783,500 | $9.79M | Health Care | Biotechnology |
| Sector and industry · Pro | ||||||||
| 3 | — | Wuxi Biologics Cayman Inc | 8.06% | 25.5% | 1,289,635 | $9.21M | ||
| 4 | — | Wuxi Apptec Co. Ltd. Class A | 5.79% | 31.2% | 265,620 | $6.62M | ||
| 5 | — | Akeso Inc | 4.68% | 35.9% | 386,000 | $5.35M | ||
| 6 | — | Jiangsu Hengrui Medicine Co Ltd | 4.45% | 40.4% | 724,508 | $5.09M | ||
| 7 | — | Shenzhen Mindray Bio-Medical Electronic | 4.36% | 44.7% | 207,755 | $4.99M | ||
| 8 | — | CSPC Pharmaceutical Group Limited Shs | 3.78% | 48.5% | 3,362,889 | $4.32M | ||
| 9 | — | Sino Biopharmaceutical Limited | 3.74% | 52.3% | 5,875,750 | $4.28M | ||
| 10 | — | Genscript Biotech Corp | 3.61% | 55.9% | 722,000 | $4.13M | ||
| 11 | — | Wuxi Apptec Co Ltd-h | 3.37% | 59.2% | 140,284 | $3.85M | ||
| 12 | — | Hansoh Pharmaceutical Group Co Ltd | 2.94% | 62.2% | 746,000 | $3.36M | ||
| 13 | — | 3sbio Inc | 2.11% | 64.3% | 1,140,500 | $2.41M | ||
| 14 | — | Yunnan Baiyao Group Co Ltd | 2.11% | 66.4% | 321,127 | $2.41M | ||
| 15 | — | Shanghai United Imaging He-A | 2.07% | 68.5% | 148,322 | $2.37M | ||
| 16 | — | Sichuan Kelun-Biotech Biop-H | 2.01% | 70.5% | 37,000 | $2.30M | ||
| 17 | — | Aier Eye Hospital Group Co-A | 1.74% | 72.2% | 1,673,663 | $1.99M | ||
| 18 | — | Zhangzhou Pientzehuang Pharmaceutical Co. Ltd. Class A | 1.67% | 73.9% | 108,634 | $1.91M | ||
| 19 | — | Pharmaron Beijing Co. Ltd. Class A | 1.56% | 75.4% | 265,875 | $1.78M | ||
| 20 | — | Xtalpi Holdings Ltd | 1.53% | 77.0% | 1,675,000 | $1.75M | ||
| 21 | — | Sichuan Kelun Pharmaceutical Co. Ltd. Class A | 1.52% | 78.5% | 286,316 | $1.74M | ||
| 22 | — | Sichuan Biokin Pharmaceutical Co.,Ltd. | 1.52% | 80.0% | 48,297 | $1.74M | ||
| 23 | — | Asymchem Laboratories (tianjin) Lt | 1.47% | 81.5% | 59,900 | $1.68M | ||
| 24 | — | Sinopharm Group Co Ltd | 1.33% | 82.8% | 804,000 | $1.52M | ||
| 25 | — | Haisco Pharmaceutical Group Co. Ltd. Class A | 1.31% | 84.1% | 161,200 | $1.49M | ||
| 26 | — | Wuxi Xdc Cayman Inc | 1.27% | 85.4% | 139,000 | $1.45M | ||
| 27 | — | Shanghai Fosun Pharmaceutical (Gro | 1.19% | 86.6% | 381,329 | $1.36M | ||
| 28 | — | Shanghai Allist Pharmaceuticals Co Ltd | 1.18% | 87.8% | 80,986 | $1.35M | ||
| 29 | — | Huadong Medicine Co Ltd | 1.14% | 88.9% | 315,641 | $1.30M | ||
| 30 | — | Shanghai Pharmaceuticals Holding Co. Ltd. Class A | 1.06% | 90.0% | 502,012 | $1.21M | ||
| 31 | — | Remegen Co Ltd_None_None | 0.98% | 90.9% | 64,050 | $1.12M | ||
| 32 | — | Remegen Co Ltd-H | 0.97% | 91.9% | 112,500 | $1.11M | ||
| 33 | — | China Resources Sanjiu Medical & Pharmaceutical Co Ltd | 0.94% | 92.8% | 299,501 | $1.08M | ||
| 34 | — | Shenzhen New Industries Biomedical Engineering Co Ltd | 0.93% | 93.8% | 141,500 | $1.06M | ||
| 35 | — | Cspc Innovation Pharmaceutical Co Ltd | 0.90% | 94.7% | 146,657 | $1.03M | ||
| 36 | — | Shanghai Raas Blood Products Co Ltd | 0.82% | 95.5% | 1,186,534 | $939.6K | ||
| 37 | — | Apt Medical Inc | 0.82% | 96.3% | 25,471 | $941.2K | ||
| 38 | — | Shenzhen Salubris Pharmaceuticals Co Ltd | 0.80% | 97.1% | 200,665 | $915.8K | ||
| 39 | — | Beijing Tongrentang Co Ltd | 0.76% | 97.9% | 246,890 | $872.5K | ||
| 40 | L | Legend Biotech Corp-adr | 0.76% | 98.6% | 44,957 | $868.6K | ||
| 41 | — | Imeik Technology Development Co. Ltd. | 0.67% | 99.3% | 54,540 | $771.3K | ||
| 42 | — | Hangzhou Tiger-a | 0.51% | 99.8% | 66,450 | $577.7K | ||
| 43 | — | Cash | 0.18% | 100.0% | 207,718 | $207.7K | ||
| 44 | — | Kangmei Pharma - Rights O | 0.00% | 100.0% | 103,989 | - | ||
| 45 | — | HKD | 0.00% | 100.0% | 890 | $113 | ||
KURE ETF All Holdings
KURE holdings total 50 positions. The top 10 holdings account for 55.9% of the fund, led by Beigene Ag at 8.8%, Innovent Biologics Inc at 8.6%, Wuxi Biologics Cayman Inc at 8.1%.
KURE portfolio concentration is relatively high, with the top 10 representing 55.9% of total assets. The largest sector exposure is Health Care at 16.5%.
KURE sectors provide a detailed breakdown. KURE overlap shows how holdings compare to other funds in your portfolio.
KURE ETF Holdings
45 of 50 holdings
- 1
Beigene Ag
6160:HKUnknown8.83% - 2
Innovent Biologics Inc
1801:HKHealth Care8.56% - 3
Wuxi Biologics Cayman Inc
2269:HKUnknown8.06% - 4
Wuxi Apptec Co. Ltd. Class A
603259:SHUnknown5.79% - 5
Akeso Inc
9926:HKUnknown4.68% - 6
Jiangsu Hengrui Medicine Co Ltd
600276:SHUnknown4.45% - 7
Shenzhen Mindray Bio-Medical Electronic
300760:SHUnknown4.36% - 8
CSPC Pharmaceutical Group Limited Shs
1093:HKHealth Care3.78% - 9
Sino Biopharmaceutical Limited
1177:KYUnknown3.74% - 10
Genscript Biotech Corp
1548:HKUnknown3.61% - 11
Wuxi Apptec Co Ltd-h
2359:HKUnknown3.37% - 12
Hansoh Pharmaceutical Group Co Ltd
3692:HKUnknown2.94% - 13
3sbio Inc
1530:HKHealth Care2.11% - 14
Yunnan Baiyao Group Co Ltd
000538:SHUnknown2.11% - 15
Shanghai United Imaging He-A
688271:SHUnknown2.07% - 16
Sichuan Kelun-Biotech Biop-H
6990:SHUnknown2.01% - 17
Aier Eye Hospital Group Co-A
300015:SHUnknown1.74% - 18
Zhangzhou Pientzehuang Pharmaceutical Co. Ltd. Class A
600436:SHUnknown1.67% - 19
Pharmaron Beijing Co. Ltd. Class A
300759:SHUnknown1.56% - 20
Xtalpi Holdings Ltd
2228:SHUnknown1.53% - 21
Sichuan Kelun Pharmaceutical Co. Ltd. Class A
002422:SHUnknown1.52% - 22
Sichuan Biokin Pharmaceutical Co.,Ltd.
688506:SHUnknown1.52% - 23
Asymchem Laboratories (tianjin) Lt
002821:SZUnknown1.47% - 24
Sinopharm Group Co Ltd
1099:HKHealth Care1.33% - 25
Haisco Pharmaceutical Group Co. Ltd. Class A
002653:HKUnknown1.31% - 26
Wuxi Xdc Cayman Inc
2268:HKUnknown1.27% - 27
Shanghai Fosun Pharmaceutical (Gro
600196:SHUnknown1.19% - 28
Shanghai Allist Pharmaceuticals Co Ltd
688578:SHUnknown1.18% - 29
Huadong Medicine Co Ltd
000963:SHUnknown1.14% - 30
Shanghai Pharmaceuticals Holding Co. Ltd. Class A
601607:SHUnknown1.06% - 31
Remegen Co Ltd_None_None
688331:SHUnknown0.98% - 32
Remegen Co Ltd-H
9995:SHUnknown0.97% - 33
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
000999:SHUnknown0.94% - 34
Shenzhen New Industries Biomedical Engineering Co Ltd
300832:SHUnknown0.93% - 35
Cspc Innovation Pharmaceutical Co Ltd
300765:SHUnknown0.90% - 36
Shanghai Raas Blood Products Co Ltd
002252:SHUnknown0.82% - 37
Apt Medical Inc
688617:SHUnknown0.82% - 38
Shenzhen Salubris Pharmaceuticals Co Ltd
002294:SHUnknown0.80% - 39
Beijing Tongrentang Co Ltd
600085:SHUnknown0.76% - 40
LEGEND BIOTECH CORP-ADR
LEGNHealth Care0.76% - 41
Imeik Technology Development Co. Ltd.
300896:SHUnknown0.67% - 42
Hangzhou Tiger-a
300347:SHUnknown0.51% - 43
Cash
Other0.18% - 44
Kangmei Pharma - Rights O
Other0.00% - 45
HKD
Other0.00%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Beigene Ag | 6160:HK | 8.830% | ||
| 2 | Innovent Biologics Inc | 1801:HK | 8.560% | ||
| 3 | Wuxi Biologics Cayman Inc | 2269:HK | 8.060% | ||
| 4 | Wuxi Apptec Co. Ltd. Class A | 603259:SH | 5.790% | ||
| 5 | Akeso Inc | 9926:HK | 4.680% | ||
| 6 | Jiangsu Hengrui Medicine Co Ltd | 600276:SH | 4.450% | ||
| 7 | Shenzhen Mindray Bio-Medical Electronic | 300760:SH | 4.360% | ||
| 8 | CSPC Pharmaceutical Group Limited Shs | 1093:HK | 3.780% | ||
| 9 | Sino Biopharmaceutical Limited | 1177:KY | 3.740% | ||
| 10 | Genscript Biotech Corp | 1548:HK | 3.610% | ||
| 11 | Wuxi Apptec Co Ltd-h | 2359:HK | 3.370% | ||
| 12 | Hansoh Pharmaceutical Group Co Ltd | 3692:HK | 2.940% | ||
| 13 | 3sbio Inc | 1530:HK | 2.110% | ||
| 14 | Yunnan Baiyao Group Co Ltd | 000538:SH | 2.110% | ||
| 15 | Shanghai United Imaging He-A | 688271:SH | 2.070% | ||
| 16 | Sichuan Kelun-Biotech Biop-H | 6990:SH | 2.010% | ||
| 17 | Aier Eye Hospital Group Co-A | 300015:SH | 1.740% | ||
| 18 | Zhangzhou Pientzehuang Pharmaceutical Co. Ltd. Class A | 600436:SH | 1.670% | ||
| 19 | Pharmaron Beijing Co. Ltd. Class A | 300759:SH | 1.560% | ||
| 20 | Xtalpi Holdings Ltd | 2228:SH | 1.530% | ||
| 21 | Sichuan Kelun Pharmaceutical Co. Ltd. Class A | 002422:SH | 1.520% | ||
| 22 | Sichuan Biokin Pharmaceutical Co.,Ltd. | 688506:SH | 1.520% | ||
| 23 | Asymchem Laboratories (tianjin) Lt | 002821:SZ | 1.470% | ||
| 24 | Sinopharm Group Co Ltd | 1099:HK | 1.330% | ||
| 25 | Haisco Pharmaceutical Group Co. Ltd. Class A | 002653:HK | 1.310% | ||
| 26 | Wuxi Xdc Cayman Inc | 2268:HK | 1.270% | ||
| 27 | Shanghai Fosun Pharmaceutical (Gro | 600196:SH | 1.190% | ||
| 28 | Shanghai Allist Pharmaceuticals Co Ltd | 688578:SH | 1.180% | ||
| 29 | Huadong Medicine Co Ltd | 000963:SH | 1.140% | ||
| 30 | Shanghai Pharmaceuticals Holding Co. Ltd. Class A | 601607:SH | 1.060% | ||
| 31 | Remegen Co Ltd_None_None | 688331:SH | 0.980% | ||
| 32 | Remegen Co Ltd-H | 9995:SH | 0.970% | ||
| 33 | China Resources Sanjiu Medical & Pharmaceutical Co Ltd | 000999:SH | 0.940% | ||
| 34 | Shenzhen New Industries Biomedical Engineering Co Ltd | 300832:SH | 0.930% | ||
| 35 | Cspc Innovation Pharmaceutical Co Ltd | 300765:SH | 0.900% | ||
| 36 | Shanghai Raas Blood Products Co Ltd | 002252:SH | 0.820% | ||
| 37 | Apt Medical Inc | 688617:SH | 0.820% | ||
| 38 | Shenzhen Salubris Pharmaceuticals Co Ltd | 002294:SH | 0.800% | ||
| 39 | Beijing Tongrentang Co Ltd | 600085:SH | 0.760% | ||
| 40 | LEGEND BIOTECH CORP-ADR | LEGN | 0.760% | ||
| 41 | Imeik Technology Development Co. Ltd. | 300896:SH | 0.670% | ||
| 42 | Hangzhou Tiger-a | 300347:SH | 0.510% | ||
| 43 | Cash | - | 0.180% | ||
| 44 | Kangmei Pharma - Rights O | - | 0.000% | ||
| 45 | HKD | - | 0.000% |

